Status:
UNKNOWN
Minimal Surgical Treatment for Obstructive Sleep Apnea (OSA)
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Sleep Apnea Syndromes, Obstructive
Eligibility:
All Genders
18-110 years
Phase:
NA
Brief Summary
Obstructive Sleep apnea carries a variety of complications and implications. While the disease could be treated using continuous positive airway pressure (CPAP) and lifestyle changes, many patients fi...
Eligibility Criteria
Inclusion
- Patients suffering from OSA, defined as AHI \> 5
Exclusion
- Patients who can use CPAP.
- Patients suffering from confounding factors with higher risk (Coagulation problems, Heart conditions, chronic obstructive pulmonary disease (COPD), or other dangerous conditions as decided by the surgeon)
- Patients suffering from other problems aggravating the OSA (Respiratory, Neurologic conditions)
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04367558
Start Date
June 1 2020
End Date
May 31 2022
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe MC,
Hadera, Israel, 38100